Research ArticleArticle
Multiple Modes of Ryanodine Receptor 2 Inhibition by Flecainide
D. Mehra, M. S. Imtiaz, D. F. van Helden, B. C. Knollmann and D. R. Laver
Molecular Pharmacology December 2014, 86 (6) 696-706; DOI: https://doi.org/10.1124/mol.114.094623
D. Mehra
School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, New South Wales, Australia (D.M., M.S.I., D.F.v.H., D.R.L.); and Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee (B.C.K.)
M. S. Imtiaz
School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, New South Wales, Australia (D.M., M.S.I., D.F.v.H., D.R.L.); and Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee (B.C.K.)
D. F. van Helden
School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, New South Wales, Australia (D.M., M.S.I., D.F.v.H., D.R.L.); and Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee (B.C.K.)
B. C. Knollmann
School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, New South Wales, Australia (D.M., M.S.I., D.F.v.H., D.R.L.); and Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee (B.C.K.)
D. R. Laver
School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, New South Wales, Australia (D.M., M.S.I., D.F.v.H., D.R.L.); and Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee (B.C.K.)

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Flecainide Inhibition of RyR2
D. Mehra, M. S. Imtiaz, D. F. van Helden, B. C. Knollmann and D. R. Laver
Molecular Pharmacology December 1, 2014, 86 (6) 696-706; DOI: https://doi.org/10.1124/mol.114.094623
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement